1-11 of 11
Thomas Fleisher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune reconstitution and survival of 100 SCID patients post–hematopoietic cell transplant: a PIDTC natural history study

Clinical Trials & Observations
Jennifer Heimall, Brent R. Logan, Morton J. Cowan, Luigi D. Notarangelo, Linda M. Griffith, Jennifer M. Puck, Donald B. Kohn, Michael A. Pulsipher, Suhag Parikh, Caridad Martinez, Neena Kapoor, Richard O’Reilly, Michael Boyer, Sung-Yun Pai, Frederick Goldman, Lauri Burroughs, Sharat Chandra, Morris Kletzel, Monica Thakar, James Connelly, Geoff Cuvelier, Blachy J. Davila Saldana, Evan Shereck, Alan Knutsen, Kathleen E. Sullivan, Kenneth DeSantes, Alfred Gillio, Elie Haddad, Aleksandra Petrovic, Troy Quigg, Angela R. Smith, Elizabeth Stenger, Ziyan Yin, William T. Shearer, Thomas Fleisher, Rebecca H. Buckley, Christopher C. Dvorak
Journal: Blood
Blood (2017) 130 (25): 2718–2727.
https://doi.org/10.1182/blood-2017-05-781849
Published: 2017
Includes: Supplemental data
Journal Articles

Combination of Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients with CLL: A Pilot Phase II Study

Inhye E. Ahn, MD, Susan Soto, Pia Nierman, Xin Tian, PhD, Janet Valdez, Jennifer Lotter, Thomas Fleisher, Sergio Rosenzweig, Shakuntala Rampertaap, Irina Maric, Maryalice Stetler-Stevenson, Constance Yuan, Gerald Marti, Adrian Wiestner, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3020.
https://doi.org/10.1182/blood.V130.Suppl_1.3020.3020
Published: 2017
Journal Articles

Transient Inhibition of the JAK1/3-STAT5 Pathway By Ruxolitinib Is Insufficient to Produce Clinical Benefit in Patients with Indolent Adult T-Cell Leukemia

Sigrid Dubois, PhD, Milos D. Miljkovic, MD, Thomas Fleisher, Jennifer Hsu, RN, Thomas A Waldmann, MD, Kevin C Conlon, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3840.
https://doi.org/10.1182/blood.V130.Suppl_1.3840.3840
Published: 2017
Journal Articles

Successful Therapy of a Patient with a Novel STAT1 Gain of Function Mutation and Life-Threatening Cytopenias with Janus Kinase Inhibitor Ruxolitinib

Katja G. Weinacht, MD PhD, Louis m Charbonnier, PhD, Ashley Plant, MD, Troy Torgerson, MD PhD, Sergei Rosenzweig, MD PhD, Thomas Fleisher, MD PhD, Luigi Daniele Notarangelo, MD
Journal: Blood
Blood (2015) 126 (23): 3434.
https://doi.org/10.1182/blood.V126.23.3434.3434
Published: 2015
Journal Articles

Causes and Consequences of Splenectomy In ALPS-FAS

Susan Price, Pamela Shaw, Jennifer Kirk, Joie Davis, Katie Perkins, Fred Gill, Thomas Fleisher, V. Koneti Rao
Journal: Blood
Blood (2010) 116 (21): 3908.
https://doi.org/10.1182/blood.V116.21.3908.3908
Published: 2010
Journal Articles

Identifying Biomarkers in the Autoimmune Lymphoproliferative Syndrome (ALPS): IL-18, TNF-á, Serum Vitamin B12, Soluble FasL, and Plasma IL-10 Levels Are Useful Adjuvant Diagnostic Tools.

Iusta Caminha, Thomas Fleisher, Julie Niemela, Ron Hornung, PhD, Joie Davis, Katie Perkins, Kennichi Dowdell, PhD, Susan Price, RN, Margaret Brown, BSc, V. Koneti Rao, MD, FRCPA, Joao Bosco Oliveira, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1647.
https://doi.org/10.1182/blood.V114.22.1647.1647
Published: 2009
Journal Articles

Lymphocyte Homeostasis FAS Pathway Is Altered in Some Patients with Immune Thrombocytopenia.

Nichola Cooper, MRCP, MRCPath, MD, V. Koneti Rao, MD, FRCPA, Thomas Fleisher, James B. Bussel, MD
Journal: Blood
Blood (2009) 114 (22): 3514.
https://doi.org/10.1182/blood.V114.22.3514.3514
Published: 2009
Journal Articles

Somatic Fas Mutations Account for Nearly One Third of Autoimmune Lymphoproliferative Syndrome (ALPS) Cases with Previously Unknown Genetic Mutations.

Kennichi Dowdell, PhD, Julie Niemela, Susan Price, Joie Davis, Katie Perkins, Janet Dale, Jennifer M. Puck, MD, Joao Bosco Oliveira, MD, PhD, Jeffrey Cohen, MD, Thomas Fleisher, MD, V. Koneti Rao, MD
Journal: Blood
Blood (2009) 114 (22): 710.
https://doi.org/10.1182/blood.V114.22.710.710
Published: 2009
Journal Articles

Use of Rituximab for Refractory Immune Cytopenias Associated with Autoimmune Lymphoproliferative Syndrome (ALPS).

Janet K. Dale, RN, Susan Price, RN, Jean Tretler, RN, Patricia Aldridge, RN, Stephanie Montague, RN MSN, Joie Davis, APRN, Fred Gill, MD, Kip R. Hartman, MD, Linda C. Stork, MD, David J. Gnarra, MD, Lakshmanan Krishnamurti, MD, Jennifer Puck, MD, Thomas Fleisher, MD, V. Koneti Rao, MD
Journal: Blood
Blood (2007) 110 (11): 1319.
https://doi.org/10.1182/blood.V110.11.1319.1319
Published: 2007
Journal Articles

Role of Somatic Fas Mutations in the Pathogenesis of Autoimmune Lymphoproliferative Syndrome (ALPS).

Kennichi C. Dowdell, PhD, Julie Niemela, BS, MT(ASCP), Janet K. Dale, RN, MPH, Jennifer Puck, MD, V. Koneti Rao, MD, Thomas Fleisher, MD, Stephen E. Straus, MD
Journal: Blood
Blood (2006) 108 (11): 3900.
https://doi.org/10.1182/blood.V108.11.3900.3900
Published: 2006
Journal Articles

IL7 Administration in Humans Results in Preferential Expansion of Naive and Memory CD4+ & CD8+ T Cells with a Relative Decrease in Regulatory T-Cells (T-Regs).

Claude Sportes, MD, Michael Krumlauf, RN, Rebecca Babb, RN, Ladan Foruraghi, RN, Janine Daub, RN, Daniele Avila, RN, Catherine Chow, MD, Hua Zhang, PhD, Kevin Chua, PhD, Terry Fry, MD, Sarfraz Memon, PhD, Frances Hakim, PhD, Thomas Fleisher, MD, Margaret Brown, BSN, Julie Engel, PhD, Renaud Buffet, MD, Michel Morre, DVM, Ronald Gress, MD, Crystal Mackall, MD
Journal: Blood
Blood (2006) 108 (11): 871.
https://doi.org/10.1182/blood.V108.11.871.871
Published: 2006